Categories
rss

FDA and CDC Recommend Pause in Use of Ixchiq (Chikungunya Vaccine, Live) in Individuals 60 Years of Age and Older While Postmarketing Safety Reports are Investigated: FDA Safety Communication

Murilo Freitas - 04:00, 11 de May de 2025309
The FDA and the CDC are recommending a pause in the use of Ixchiq (Chikungunya Vaccine, Live) in individuals 60 years of age and older while the Agencies investigate postmarketing reports of serious adverse events, including neurologic and cardiac events, in individuals who have received the vaccine

http://www.fda.gov/safety/medical-product-safety-information/fda-and-cdc-recommend-pause-use-ixchiq-chikungunya-vaccine-live-individuals-60-years-age-and-older

 
Categories
rss

FDA Advises Consumers, Tattoo Artists, and Retailers to Avoid Using or Selling Certain Sacred Tattoo Ink Products Contaminated with Microorganisms

Murilo Freitas - 04:00, 6 de May de 2025290
The FDA is alerting consumers, tattoo artists, and retailers of the potential for serious injury from use of tattoo inks that are contaminated with bacteria, including Pseudomonas aeruginosa.

http://www.fda.gov/safety/medical-product-safety-information/fda-advises-consumers-tattoo-artists-and-retailers-avoid-using-or-selling-certain-sacred-tattoo-ink

 
PRAIS 2.0